These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis. Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study. Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427 [TBL] [Abstract][Full Text] [Related]
5. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging. Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054 [TBL] [Abstract][Full Text] [Related]
6. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Vita T; Okada DR; Veillet-Chowdhury M; Bravo PE; Mullins E; Hulten E; Agrawal M; Madan R; Taqueti VR; Steigner M; Skali H; Kwong RY; Stewart GC; Dorbala S; Di Carli MF; Blankstein R Circ Cardiovasc Imaging; 2018 Jan; 11(1):e007030. PubMed ID: 29335272 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/ Tanaka TD; Nagai T; Nagoshi T; Yoshimura M J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review. Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587 [TBL] [Abstract][Full Text] [Related]
16. Localization of Late Gadolinium Enhancement and Its Association with Ventricular Tachycardia in Patients with Cardiac Sarcoidosis. Yodogawa K; Fukushima Y; Tachi M; Fujimoto Y; Hagiwara K; Oka E; Hayashi H; Murata H; Yamamoto T; Iwasaki YK; Amano Y; Kumita SI; Shimizu W Int Heart J; 2022; 63(2):235-240. PubMed ID: 35354745 [TBL] [Abstract][Full Text] [Related]
17. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis. Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490 [TBL] [Abstract][Full Text] [Related]
18. Spatial dispersion analysis of LGE-CMR for prediction of ventricular arrhythmias in patients with cardiac sarcoidosis. Aronis KN; Okada DR; Xie E; Daimee UA; Prakosa A; Gilotra NA; Wu KC; Trayanova N; Chrispin J Pacing Clin Electrophysiol; 2021 Dec; 44(12):2067-2074. PubMed ID: 34766627 [TBL] [Abstract][Full Text] [Related]
19. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. Bravo PE; Raghu G; Rosenthal DG; Elman S; Petek BJ; Soine LA; Maki JH; Branch KR; Masri SC; Patton KK; Caldwell JH; Krieger EV Int J Cardiol; 2017 Aug; 241():457-462. PubMed ID: 28318664 [TBL] [Abstract][Full Text] [Related]
20. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]